The clinic reports more patients arriving on Ozempic, Wegovy or Mounjaro, and says the drugs' effects on the face now factor into surgical planning.
Recap by typeshit. Post by @face_toronto on Instagram.
BMO's Evan Seigerman expects US share losses to weigh on Ozempic sales, while the 25% CagriSema figure comes from a post-hoc subgroup, not the full trial's 22.7%.
Beauty companies are reportedly exploring products aimed at facial changes linked to rapid weight loss on GLP-1 drugs.
A search page for retatrutide news with no specific story attached, so there is little new beyond recent coverage.
2:06:48
A live Q&A stream from DOWNSIZED taking viewer questions about GLP-1 medications, including Zepbound, Wegovy and Foundayo.
Novo says results held across menopausal stages among 1,900 women, from 23.1% to 26.7%, against about 2% on placebo. The piece also pitches obesity ETFs.
The trial is testing whether tirzepatide can improve insulin sensitivity and help manage diabetes in adults with type 1, an untested use for the drug.
Loading…